GLP-1 Based Therapies
Glucagon-Like Peptide-1 (GLP-1) receptor agonists are among the most clinically validated tools in modern metabolic medicine. GLP-1 is a gut-derived hormone that regulates blood sugar, slows gastric emptying, and — crucially — reduces appetite by acting on hunger centres in the brain.
Our GLP-1 protocols are ideal for patients who struggle with persistent hunger, insulin resistance, or a history of yo-yo dieting. Clinical data consistently shows significant, sustained reductions in body weight alongside improvements in blood glucose, cholesterol, and cardiovascular risk markers.